The University of Chicago Header Logo

Connection

Hedy Kindler to Recombinant Fusion Proteins

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Recombinant Fusion Proteins.
Hedy Kindler
Connection Strength
0.036
Recombinant Fusion Proteins
  1. A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma. Invest New Drugs. 2020 04; 38(2):457-467.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.